Essential Partners
AMRX icon

Essential Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Essential Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22K Hold
1,091
– – 0.01% 879
2026
Q2 		$18.9K Sell
1,091
-2,136
-66% -$29.3K 0.01% 934
2026
Q1 		$40.1K Hold
3,227
– – 0.01% 659
2025
Q4 		$40.7K Buy
3,227
+14
+0.4% +$160 0.01% 663
2025
Q3 		$32.2K Buy
3,213
+502
+19% +$4.51K 0.01% 738
2025
Q2 		$21.9K Buy
+2,711
New +$20.4K 0.01% 651

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Essential Partners's AMRX Position: Q3 2026 in Review

Essential Partners held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 1,091 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #879.

Essential Partners first reported a position in AMRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $40.7K in Q4 2025. 43 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Essential Partners held 1,091 shares of Amneal Pharmaceuticals worth $22K as of Q3 2026.
  • Essential Partners left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
  • Amneal Pharmaceuticals made up 0.01% of Essential Partners's portfolio in Q3 2026, its #879 holding.
  • Essential Partners first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Amneal Pharmaceuticals position peaked at $40.7K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.